OXFORD ANAT BRG LT X-SM SZ 3 PMA
Report
- Report Number
- 3002806535-2025-00140
- Event Type
- Injury
- Date Received
- April 2, 2025
- Date of Event
- March 7, 2025
- Report Date
- August 28, 2025
- Manufacturer
- BIOMET UK LTD.
- Product Code
- NRA
- PMA / PMN Number
- P010014
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL AND CORRECTED INFORMATION. THE FOLLOWING SECTIONS WERE UPDATED: B4, B5, B7, G3, G6, H1, H2, H3, H11. THE FOLLOWING SECTION WAS CORRECTED: H6. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL REPORT WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.
(B)(4). D10 ¿ 166570, OXF UNI CMNTLS TIB SZ AA LM, LOT # 3220112. 154912, OXF PH3 CEMENTLESS FEM SZ XSM, LOT # 3093630. G2 ¿ FOREIGN ¿ GERMANY. INVESTIGATION OF THIS INCIDENT IS CURRENTLY ONGOING. ONCE THE INVESTIGATION IS COMPLETED, A SUPPLEMENTAL MEDWATCH 3500A WILL BE SUBMITTED.
THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. THE FOLLOWING SECTIONS WERE UPDATED: A2, B4, B5, G3, G6, H1, H2, H3, H11. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL REPORT WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.
THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL AND CORRECTED INFORMATION. THE FOLLOWING SECTIONS WERE UPDATED: B4, B5, D9, G3, G6, H1, H2, H3, H6, H11. THE FOLLOWING SECTION WAS CORRECTED: H4. VISUAL EXAMINATION OF THE PRODUCT RETURN SHOWS THAT THE BEARING EXHIBITS SIGNS OF USE (WEAR) AND CONFIRMING COMPLAINT OF FRACTURE, NOT ALL PIECES WERE RETURNED. PERFORMED DIMENSIONAL ANALYSIS RESULTS ARE WITHIN SPECIFICATION. A REVIEW OF THE DEVICE MANUFACTURING RECORDS CONFIRMED NO ABNORMALITIES OR DEVIATIONS THAT COULD BE RELATED TO THE REPORTED EVENT. REVIEW OF THE COMPLAINT HISTORY FOUND NO ADDITIONAL RELATED COMPLAINTS FOR THIS ITEM AND THE REPORTED PART AND LOT COMBINATION. MEDICAL RECORDS WERE PROVIDED AND REVIEWED BY A HEALTH CARE PROFESSIONAL. THE REVIEW IDENTIFIED MECHANICAL COMPLICATION DUE TO AN OXFORD TYPE MEDIAL CARRIAGE PROSTHESIS WITH INLAY FRACTURE. X-RAY CONFIRMED IMPLANT FRACTURE. INLAY BROKE CENTRALLY INTO 2 PARTS WHICH WERE REMOVED COMPLETELY. NEW INLAY WAS PLACED WITH BALANCE OF THE JOINT AND CORRECT FEMORAL PATELLAR ARTICULATION WITH NO COMPLICATIONS. BASED ON THE AVAILABLE INFORMATION, THE REPORTED EVENT CAN BE CONFIRMED. A DEFINITIVE ROOT CAUSE COULD NOT BE DETERMINED. HOWEVER, A CONTRIBUTING FACTOR MAY HAVE BEEN THE PATIENT¿S FALL, WHICH OCCURRED DUE TO AN UNKNOWN CAUSE, AS NO REASON FOR THE FALL WAS MENTIONED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL REPORT WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.
IT WAS REPORTED THAT THE PATIENT UNDERWENT REVISION SURGERY OF THE LEFT KNEE TEN YEARS AND EIGHT MONTHS POST IMPLANTATION DUE TO A BEARING FRACTURE AFTER A FALL DUE TO UNKNOWN CAUSE. THE INLAY WAS EXCHANGED WITHOUT COMPLICATIONS. THE FEMUR AND TIBIA COMPONENTS REMAINED IMPLANTED. DUE DILIGENCE IS IN PROGRESS FOR THIS COMPLAINT; TO DATE NO ADDITIONAL INFORMATION OR PRODUCT HAS BEEN RECEIVED.
IT WAS REPORTED THAT THE PATIENT UNDERWENT REVISION SURGERY OF THE LEFT KNEE TEN YEARS AND EIGHT MONTHS POST IMPLANTATION DUE TO A BEARING FRACTURE AFTER A FALL. DUE DILIGENCE IS IN PROGRESS FOR THIS COMPLAINT; TO DATE NO ADDITIONAL INFORMATION OR PRODUCT HAS BEEN RECEIVED.
NO FURTHER EVENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT.
NO FURTHER EVENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2333755 | OXFORD ANAT BRG LT X-SM SZ 3 PMA | PROSTHESIS, KNEE, FEMOROTIBIAL, UNICOMPARTMENTAL | NRA | BIOMET UK LTD. | 3226998 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 92 YR | Female | Required Intervention| H | SEE H11 NARRATIVE |